指南与共识神经肿瘤

EANS-EANO胶质瘤切除范围指南

EANS-EANO guidelines on the extent of resection in gliomas.
指南 / 共识 · Neuro Oncol · 2026-01-01

欧洲神经外科协会与欧洲神经肿瘤协会联合工作组评估胶质瘤切除范围(EOR)证据并制定推荐。EOR常规由术后磁共振确定,与生存、癫痫、神经认知、生活质量、神经状态及放化疗规划相关(证据等级I-IV),据此对新诊断胶质母细胞瘤(A级)、复发胶质母细胞瘤(C级)、新诊断(B级)和复发(良好实践点)IDH突变胶质瘤、儿童室管膜瘤(B级)和成人室管膜瘤(良好实践点)及WHO CNS 1级肿瘤(良好实践点)的切除给出不同级别推荐。

要点

  • EOR常规由术后磁共振成像确定
  • EOR与生存及癫痫、神经认知、生活质量、神经状态和放化疗规划相关
  • 对新诊断胶质母细胞瘤的切除推荐为A级

核心结论

  • EOR可能影响生存及癫痫、神经认知、生活质量、神经状态和放化疗规划,证据等级为I-IV。
  • 针对不同胶质瘤场景可做出不同级别的切除推荐。

研究设计与样本

  • EANS与EANO联合工作组评估胶质瘤EOR数据、评价证据等级并撰写推荐。

主要发现

  • EOR常规由术后磁共振成像确定。
  • EOR可能与生存相关,并可能影响癫痫、神经认知、生活质量、神经状态及放化疗规划(证据等级I-IV)。

关键数值与推荐

  • 新诊断胶质母细胞瘤切除推荐为A级。
  • 复发胶质母细胞瘤切除推荐为C级。
  • 新诊断IDH突变胶质瘤切除推荐为B级。
  • 复发IDH突变胶质瘤切除推荐为良好实践点。
  • 儿童室管膜瘤切除推荐为B级;成人室管膜瘤及WHO CNS 1级肿瘤切除推荐为良好实践点。

临床怎么用

  • 术后应常规行磁共振成像以确定EOR。
  • 制定切除策略时需综合考虑EOR对生存、癫痫、神经认知、生活质量、神经状态及放化疗规划的影响。

局限性

  • 用于个体化治疗决策的证据水平仍为中等。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intense efforts are employed to optimize neurosurgical resection of gliomas in different clinical scenarios. However, the level of evidence employed toward personalized treatment decisions is still moderate. Therefore, a joint task force was created by the European Association for Neurosurgical Societies (EANS) and the European Association of Neuro-Oncology (EANO) in order to provide interdisciplinary guidance on the extent of resection (EOR) in glioma surgery. This task force assessed the data on the EOR in gliomas, evaluated the level of evidence, and composed recommendations. The EOR is determined routinely by postoperative magnetic resonance imaging. Since EOR may be associated with survival and may have an impact on epilepsy, neurocognition, quality of life, neurological status, and also on planning of radiation and pharmacotherapy (evidence classes I-IV), recommendations of different levels can be made for the resection of newly diagnosed glioblastomas (level A), recurrent glioblastomas (level C), newly diagnosed (level B) and recurrent (good practice point) IDH mutant gliomas, ependymomas in children (level B) and adults (good practice point) as well as World Health Organization CNS grade 1 tumors (good practice point). We hereby report the outcome of this collaborative effort by the joint task force between EANS and EANO.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Goldbrunner R, Foroglou N, Signorelli F, et al. EANS-EANO guidelines on the extent of resection in gliomas. Neuro Oncol. 2026. PMID: 40973061. doi:10.1093/neuonc/noaf217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。